Sidley Austin LLP represented Supira Medical, Inc. in the transaction. Supira Medical, Inc. (Supira), a clinical-stage company, announced it has closed an oversubscribed Series E financing...
Supira Medical’s $120 Million Series E Financing Round
Vera Therapeutics’ Exclusive License Agreement with Stanford University
Sidley Austin represented Vera Therapeutics, Inc. in the transaction. Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments...
Realta Fusion’s $9 Million Seed Financing Round
Sidley advised Khosla Ventures on its investment. Realta Fusion, Inc. announced its $9 million seed financing round led by Khosla Ventures. Wisconsin Alumni Research Foundation, and...
Lepu Biopharma and Keymed Biosciences’ Licensing Agreement with AstraZeneca AB
Zhong Lun advised Lepu Bio on the deal while Sidley represented Keymed Biosciences. Lepu Biopharma Co., Ltd and Keymed Biosciences Inc. signed a global exclusive license agreement...
Akeso’s US$5 Billion Licensing Agreement With Summit Therapeutics Title
Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...
Nassau Financial Group’s Acquisition of Delaware Life
Sidley advised Nassau Financial Group on the deal. Nassau Financial Group, a Golden Gate Capital portfolio company, announced the acquisition of Delaware Life Insurance Company of New...
United Airlines and Honeywell UOP Ecofining’s Investment in Alder Fuels
Sidley Austin advised United Airlines on the deal, while Crowell & Moring advised Honeywell. Latham & Watkins represented Alder Fuels in the transaction. United Airlines announced its...